The Cooper Companies Inc COO
(Start of Section)(Start of Section)Laatste Koers
94,89
Verandering 1 Dag
0,45|0,48%
Per 24-05-2024
16:40:34 EDT | USD
Minimaal 15 minuten vertraagd.
(End of Section) (Start of Section)Bid/Offers | Laagste - hoogste dag | Volume | 90d Ave Vol | Mkt Kap |
---|
94,08 - 95,71 | 93,79 - 95,11 | 691.431 | 1.079.234 | 18,86Bil |
(End of Section)(Start of Section)Laatste slotkoers | Laagste - hoogste koers van de afgelopen 52 weken | Koers-winst | Opbrengst % | ISIN |
---|
94,44 | 75,94 - 104,07 | 65,10 | 0,01 | US2166485019 |
(End of Section) (End of Section)(Start of Section)The Cooper Companies Inc Koers
(End of Section)(Start of Section) | 2021 | 2022 | 2023 |
---|
Meer... |
Inkomsten | 2.922,50 | 3.308,40 | 3.593,20 |
---|
Exploitatie-inkomsten | 505,80 | 507,60 | 533,10 |
---|
Netto-inkomsten | 2.944,70 | 385,80 | 294,20 |
---|
Basis-EPS | 14,95 | 1,96 | 1,49 |
---|
Gem. uitstaande verwaterde aandelen | 199 | 199 | 199 |
---|
Vlottende activa | 1.465,30 | 1.533,60 | 1.704,90 |
---|
Langlopende activa | 8.140,90 | 9.958,70 | 9.954,00 |
---|
Totaal activa | 9.606,20 | 11.492,30 | 11.658,90 |
---|
Kortlopende verplichtingen | 732,10 | 1.280,20 | 969,00 |
---|
Totaal verplichtingen | - | - | - |
---|
Totaal eigen vermogen | 6.941,80 | 7.174,50 | 7.550,80 |
---|
Bedrijfscashflow | 738,60 | 692,40 | 607,50 |
---|
Investeringsuitgaven | -214,40 | -242,00 | -392,50 |
---|
Vrije cashflow | 524,20 | 450,40 | 215,00 |
---|
(End of Section)In miljoenen, behalve "Basic EPS". Valuta is USD.
(Start of Section)Bedrijfsprofiel
The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women’s care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.
Sector
GezondheidszorgIndustrie
Medische instrumenten en hulpmiddelenStijl aandelen
Midden gemengdEinde boekjaar
oktoberWerknemers
15.000 (End of Section)(Start of Section)Meer... |
Koers-winst laatste 12 maanden | 64,46 |
---|
Koers/Boekwaarde | 2,44 |
---|
Koers/omzet laatste 12 maanden | 5,14 |
---|
Inkomstengroei (3 jaar gem) | 13,91 |
---|
Groei Winst per aandeel (3 jaar gem) | - |
---|
Exploitatiemarge % laatste 12 maanden | 14,84 |
---|
Nettomarge % laatste 12 maanden | 8,19 |
---|
ROE laatste 12 maanden | 4,00 |
---|
Schuld/eigen vermogen | 0,33 |
---|
(End of Section)(Start of Section) | Voorafgaande | Laatste |
---|
|
Declaratie datum | 14-12-22 | 12-07-23 |
---|
Ex-Div | 20-01-23 | 26-07-23 |
---|
Betaald | 10-02-23 | 11-08-23 |
---|
Bedrag | 0,01 | 0,01 |
---|
(End of Section)